Clinical Trial Update: Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating an imaging procedure using ALA to identify residual tumor in Grade IV malignant astrocytoma (brain tumor).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors

Drugs mentioned

• ALA imaging procedure (5-ALA (5-aminolevulinic acid) imaging)

Snippet

Sponsor: Andrew Sloan, MD | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED